Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 287

1.

Emergence of trimethoprim-sulfamethoxazole resistance in the AIDS era.

Martin JN, Rose DA, Hadley WK, Perdreau-Remington F, Lam PK, Gerberding JL.

J Infect Dis. 1999 Dec;180(6):1809-18.

PMID:
10558935
[PubMed - indexed for MEDLINE]
Free Article
3.

Trimethoprim-sulfamethoxazole as a viable treatment option for infections caused by methicillin-resistant Staphylococcus aureus.

Grim SA, Rapp RP, Martin CA, Evans ME.

Pharmacotherapy. 2005 Feb;25(2):253-64. Review.

PMID:
15767239
[PubMed - indexed for MEDLINE]
4.

Successful prophylaxis against Pneumocystis carinii pneumonia in HIV-infected children using smaller than recommended dosages of trimethoprim-sulfamethoxazole.

Fisher RG, Nageswaran S, Valentine ME, McKinney RE Jr.

AIDS Patient Care STDS. 2001 May;15(5):263-9.

PMID:
11530767
[PubMed - indexed for MEDLINE]
5.

Trimethoprim/sulfamethoxazole for treatment of severe Staphylococcus aureus infections.

Adra M, Lawrence KR.

Ann Pharmacother. 2004 Feb;38(2):338-41. Epub 2003 Dec 30. Review.

PMID:
14742775
[PubMed - indexed for MEDLINE]
6.

Prevalence of antimicrobial resistance among urinary tract pathogens isolated from female outpatients across the US in 1999.

Karlowsky JA, Jones ME, Thornsberry C, Critchley I, Kelly LJ, Sahm DF.

Int J Antimicrob Agents. 2001 Aug;18(2):121-7.

PMID:
11516934
[PubMed - indexed for MEDLINE]
7.

A randomized trial of N-acetylcysteine for prevention of trimethoprim-sulfamethoxazole hypersensitivity reactions in Pneumocystis carinii pneumonia prophylaxis (CTN 057). Canadian HIV Trials Network 057 Study Group.

Walmsley SL, Khorasheh S, Singer J, Djurdjev O.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Dec 15;19(5):498-505.

PMID:
9859964
[PubMed - indexed for MEDLINE]
8.

Trimethoprim-sulfamethoxazole activity and pharmacodynamics against glycopeptide-intermediate Staphylococcus aureus.

Close SJ, McBurney CR, Garvin CG, Chen DC, Martin SJ.

Pharmacotherapy. 2002 Aug;22(8):983-9.

PMID:
12173801
[PubMed - indexed for MEDLINE]
9.

Reduced toxicity with gradual initiation of trimethoprim-sulfamethoxazole as primary prophylaxis for Pneumocystis carinii pneumonia: AIDS Clinical Trials Group 268.

Para MF, Finkelstein D, Becker S, Dohn M, Walawander A, Black JR.

J Acquir Immune Defic Syndr. 2000 Aug 1;24(4):337-43.

PMID:
11015150
[PubMed - indexed for MEDLINE]
10.

Failure of trimethoprim/sulfamethoxazole prophylaxis for Pneumocystis carinii pneumonia with concurrent leucovorin use.

Razavi B, Lund B, Allen BL, Schlesinger L.

Infection. 2002 Jan;30(1):41-2.

PMID:
11876516
[PubMed - indexed for MEDLINE]
11.

Altered trimethoprim-sulfamethoxazole ratios for prophylaxis and treatment of Toxoplasma gondii and Pneumocystis carinii dual infections in rat model.

Brun-Pascaud M, Chau F, Garry L, Farinotti R, Derouin F, Girard PM.

J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Nov 1;13(3):201-7.

PMID:
8898664
[PubMed - indexed for MEDLINE]
12.

Does trimethoprim-sulfamethoxazole prophylaxis for HIV induce bacterial resistance to other antibiotic classes? Results of a systematic review.

Sibanda EL, Weller IV, Hakim JG, Cowan FM.

Clin Infect Dis. 2011 May;52(9):1184-94. doi: 10.1093/cid/cir067. Review.

PMID:
21467024
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Trimethoprim-sulfamethoxazole for the prevention of methicillin-resistant Staphylococcus aureus pneumonia in severely burned patients.

Kimura A, Mochizuki T, Nishizawa K, Mashiko K, Yamamoto Y, Otsuka T.

J Trauma. 1998 Aug;45(2):383-7.

PMID:
9715201
[PubMed - indexed for MEDLINE]
14.
15.

Increasing clindamycin resistance among methicillin-resistant Staphylococcus aureus in 57 northeast United States military treatment facilities.

Braun L, Craft D, Williams R, Tuamokumo F, Ottolini M.

Pediatr Infect Dis J. 2005 Jul;24(7):622-6.

PMID:
15999004
[PubMed - indexed for MEDLINE]
16.

Treatment of experimental endocarditis due to methicillin-susceptible or methicillin-resistant Staphylococcus aureus with trimethoprim-sulfamethoxazole and antibiotics that inhibit cell wall synthesis.

de Górgolas M, Avilés P, Verdejo C, Fernández Guerrero ML.

Antimicrob Agents Chemother. 1995 Apr;39(4):953-7.

PMID:
7786002
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Risk factors for trimethoprim-sulfamethoxazole resistance in patients with acute uncomplicated cystitis.

Colgan R, Johnson JR, Kuskowski M, Gupta K.

Antimicrob Agents Chemother. 2008 Mar;52(3):846-51. Epub 2007 Dec 17.

PMID:
18086847
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Safety of dapsone as Pneumocystis carinii pneumonia prophylaxis in human immunodeficiency virus-infected patients with allergy to trimethoprim/sulfamethoxazole.

Beumont MG, Graziani A, Ubel PA, MacGregor RR.

Am J Med. 1996 Jun;100(6):611-6.

PMID:
8678080
[PubMed - indexed for MEDLINE]
19.

[In vitro sensitivity of methicillin-resistant Staphylococcus aureus to fusidic acid and trimethoprim-sulfamethoxazole].

Memikoğlu KO, Bayar B, Kurt O, Cokça F.

Mikrobiyol Bul. 2002 Apr;36(2):141-5. Turkish.

PMID:
12652865
[PubMed - indexed for MEDLINE]
20.

In vitro and in vivo efficacy of the combination trimethoprim-sulfamethoxazole against clinical isolates of methicillin-resistant Staphylococcus aureus.

Elwell LP, Wilson HR, Knick VB, Keith BR.

Antimicrob Agents Chemother. 1986 Jun;29(6):1092-4.

PMID:
3488022
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk